A comparison of methylene blue and lymphazurin in breast cancer sentinel node mapping

Blessing, W. D., Stolier, A. J., Teng, S. C., Bolton, J. S. and Fuhrman, G. M. (2002). A comparison of methylene blue and lymphazurin in breast cancer sentinel node mapping. In: 3rd Annual Meeting of the American Society of Breast Surgeons, Boston, MA, United States, (341-345). 24-28 April 2002.


Author Blessing, W. D.
Stolier, A. J.
Teng, S. C.
Bolton, J. S.
Fuhrman, G. M.
Title of paper A comparison of methylene blue and lymphazurin in breast cancer sentinel node mapping
Conference Paper Type Fully Published Paper
Conference name 3rd Annual Meeting of the American Society of Breast Surgeons
DOI 10.1016/S0002-9610(02)00948-0
Conference location Boston, MA, United States
Conference dates 24-28 April 2002
Journal name American Journal of Surgery   Check publisher's open access policy
Publisher Elsevier
Publication date 2002
Volume number 184
Issue number 4
ISSN 0002-9610
1879-1883
Start page 341
End page 345
Total pages 4
Language eng
Abstract/Summary Background: When lymphazurin became unavailable to our institution, we elected to employ methylene blue to perform sentinel node mapping for patients with breast cancer. The purpose of this study was to compare methylene blue and lymphazurin for performing sentinel node mapping for breast cancer. Methods: We evaluated our sentinel node mapping experience from April 1, 2001 to March 31, 2002. Patients were divided into two groups based on the dye used for lymphatic mapping. The two groups were compared to evaluate the results of the sentinel node mapping procedure. Results: During the study period a total of 199 patients were evaluated with sentinel node mapping, 87 with lymphazurin and 112 with methylene blue. The two groups were similar in demonstrating the success of the sentinel node procedure, nodes identified per case, and technique used for node identification (colloid or dye, or both). Conclusions: In our initial experience, methylene blue appears to be equivalent to lymphazurin for sentinel node mapping in breast cancer.
Keyword Breast Cancer
Lymphazurin
Radiocolloid
Methylene blue
Sentinel node mapping
INTRAOPERATIVE GAMMA-PROBE
EARLY-STAGE MELANOMA
LYMPH-NODE
MALIGNANT-MELANOMA
ISOSULFAN BLUE
DYE
BIOPSY
LYMPHOSCINTIGRAPHY
IDENTIFICATION
LOCALIZATION
Q-Index Code E1
Q-Index Status Provisional Code
Institutional Status Non-UQ

Document type: Conference Paper
Sub-type: Fully Published Paper
Collection: School of Medicine Publications
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 58 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 64 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Access Statistics: 28 Abstract Views  -  Detailed Statistics
Created: Mon, 14 Mar 2011, 10:49:06 EST